skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 58,095  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: language: English remove resource type: Newsletter Articles remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Mindfulness Training Can Help Improve Eating Patterns
Material Type:
Newsletter Article
Add to My Research

Mindfulness Training Can Help Improve Eating Patterns

Tufts University Health & Nutrition Letter, 2024, Vol.42 (4), p.2

COPYRIGHT 2024 Tufts University Health & Nutrition Letter ;ISSN: 1526-0143 ;EISSN: 2169-4230

Full text available

2
CRISPR Therapeutics top decliner in Spear Holdings RSC Ltd plunges 18.2% in 49 days; +7c [0.1%]
Material Type:
Newsletter Article
Add to My Research

CRISPR Therapeutics top decliner in Spear Holdings RSC Ltd plunges 18.2% in 49 days; +7c [0.1%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 18, 2024

Digital Resources/Online E-Resources

3
Liquidia (LQDA: $12.71) decreases; -3c [0.2%]
Material Type:
Newsletter Article
Add to My Research

Liquidia (LQDA: $12.71) decreases; -3c [0.2%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 18, 2024

Digital Resources/Online E-Resources

4
Intercept Presents New Data Demonstrating the Impact of OCA-Bezafibrate Combination Therapy on ALP and Metabolic Outcomes After Six Months of Treatment at Digestive Disease Week® 2024
Material Type:
Newsletter Article
Add to My Research

Intercept Presents New Data Demonstrating the Impact of OCA-Bezafibrate Combination Therapy on ALP and Metabolic Outcomes After Six Months of Treatment at Digestive Disease Week® 2024

NASDAQ OMX's News Release Distribution Channel, 2024

GlobeNewswire, Inc.

Digital Resources/Online E-Resources

5
Morphic Holding (MORF: $29.23) loses $159 million (9.8%) in MCap, steepest heavyweight fall in Health Care Sector; -$3.18 [9.8%]
Material Type:
Newsletter Article
Add to My Research

Morphic Holding (MORF: $29.23) loses $159 million (9.8%) in MCap, steepest heavyweight fall in Health Care Sector; -$3.18 [9.8%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 18, 2024

Digital Resources/Online E-Resources

6
Orchestra BioMed Holdings (OBIO: $5.21) soars 13%; +59c [12.8%]
Material Type:
Newsletter Article
Add to My Research

Orchestra BioMed Holdings (OBIO: $5.21) soars 13%; +59c [12.8%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 18, 2024

Digital Resources/Online E-Resources

7
INTERNATIONAL PATENT: ACTELION PHARMACEUTICALS LTD FILES APPLICATION FOR "COMBINATION OF MACITENTAN AND TADALAFIL FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION"
Material Type:
Newsletter Article
Add to My Research

INTERNATIONAL PATENT: ACTELION PHARMACEUTICALS LTD FILES APPLICATION FOR "COMBINATION OF MACITENTAN AND TADALAFIL FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION"

US Fed News Service, Including US State News, 2024

Copyright HT Digital Streams Limited May 18, 2024

Digital Resources/Online E-Resources

8
Tenax Therapeutics (TENX: $3.57) decreases; -2c [0.6%]
Material Type:
Newsletter Article
Add to My Research

Tenax Therapeutics (TENX: $3.57) decreases; -2c [0.6%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 18, 2024

Digital Resources/Online E-Resources

9
Hong Kong: Health Bureau holds World Family Doctor Day Symposium to confer with healthcare professionals on way forward for promoting primary healthcare services
Material Type:
Newsletter Article
Add to My Research

Hong Kong: Health Bureau holds World Family Doctor Day Symposium to confer with healthcare professionals on way forward for promoting primary healthcare services

Hong Kong Government News, 2024

Copyright 2017 Contify.com

Digital Resources/Online E-Resources

10
Galectin Therapeutics top gainer in Stock Yards Bank Trust soars 31.4% in 49 days; +10c [3.2%]
Material Type:
Newsletter Article
Add to My Research

Galectin Therapeutics top gainer in Stock Yards Bank Trust soars 31.4% in 49 days; +10c [3.2%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 18, 2024

Digital Resources/Online E-Resources

11
Arthritis Rheumatology Issues Research Articles in May 2024 Edition
Material Type:
Newsletter Article
Add to My Research

Arthritis Rheumatology Issues Research Articles in May 2024 Edition

Targeted News Service, 2024

Targeted News Service

Digital Resources/Online E-Resources

12
Hong Kong: Family doctor symposium held
Material Type:
Newsletter Article
Add to My Research

Hong Kong: Family doctor symposium held

Hong Kong Government News, 2024

Copyright 2017 Contify.com

Digital Resources/Online E-Resources

13
Inhibikase Therapeutics (IKT: $1.73) drops 1.7% on slipping relative strength; reports deterioration in Loss; -3c [1.7%]
Material Type:
Newsletter Article
Add to My Research

Inhibikase Therapeutics (IKT: $1.73) drops 1.7% on slipping relative strength; reports deterioration in Loss; -3c [1.7%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 18, 2024

Digital Resources/Online E-Resources

14
Aerovate Therapeutics (AVTE: $20.57) down 6.1% after a downgrade this week; -$1.34 [6.1%] Vol Index 1.3 [1 is avg]
Material Type:
Newsletter Article
Add to My Research

Aerovate Therapeutics (AVTE: $20.57) down 6.1% after a downgrade this week; -$1.34 [6.1%] Vol Index 1.3 [1 is avg]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 18, 2024

Digital Resources/Online E-Resources

15
Use of natural herbs can prevent hypertension
Material Type:
Newsletter Article
Add to My Research

Use of natural herbs can prevent hypertension

Ghana News Agency (GNA), 2024

2022 Ghana News Agency (GNA) Provided by SyndiGate Media Inc. (Syndigate.info).

Digital Resources/Online E-Resources

16
Mineralys Therapeutics (MLYS: $13.0) drops 1.1%; -15c [1.1%]
Material Type:
Newsletter Article
Add to My Research

Mineralys Therapeutics (MLYS: $13.0) drops 1.1%; -15c [1.1%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 18, 2024

Digital Resources/Online E-Resources

17
Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW)
Material Type:
Newsletter Article
Add to My Research

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW)

PR Newswire, 2024

Copyright PR Newswire Association LLC May 18, 2024

Digital Resources/Online E-Resources

18
Merck Foundation marking “World Hypertension Day” by providing 760 scholarships for future Cardiovascular, Diabetes, and Endocrinology experts in 52 countries
Material Type:
Newsletter Article
Add to My Research

Merck Foundation marking “World Hypertension Day” by providing 760 scholarships for future Cardiovascular, Diabetes, and Endocrinology experts in 52 countries

M2 Presswire, 2024

Copyright © M2 Communications, 2024

Digital Resources/Online E-Resources

19
Pulmonary Circulation Issues Research Articles in April 2024 Edition
Material Type:
Newsletter Article
Add to My Research

Pulmonary Circulation Issues Research Articles in April 2024 Edition

Targeted News Service, 2024

Targeted News Service

Digital Resources/Online E-Resources

20
OMRON Healthcare's Presence at Heart Rhythm 2024 in the U.S
Material Type:
Newsletter Article
Add to My Research

OMRON Healthcare's Presence at Heart Rhythm 2024 in the U.S

PR Newswire, 2024

Copyright PR Newswire Association LLC May 17, 2024

Digital Resources/Online E-Resources

Results 1 - 20 of 58,095  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1994  (33)
  2. 1994 To 2000  (240)
  3. 2001 To 2007  (2,062)
  4. 2008 To 2015  (8,310)
  5. After 2015  (47,451)
  6. More options open sub menu

Subject 

  1. Hypertension  (49,933)
  2. Blood Pressure  (19,027)
  3. Diabetes  (11,519)
  4. Pulmonary Hypertension  (9,001)
  5. Pharmaceutical Industry  (6,881)
  6. Patients  (6,866)
  7. Clinical Trials  (6,825)
  8. Heart Failure  (6,036)
  9. Cardiovascular Disease  (6,004)
  10. Stockholders  (5,954)
  11. Fda Approval  (5,899)
  12. Earnings Per Share  (5,778)
  13. Covid-19  (4,765)
  14. Corporate Profits  (4,739)
  15. Biotechnology Industry  (4,662)
  16. Pharmaceuticals  (4,662)
  17. Coronaviruses  (4,458)
  18. Drug Dosages  (4,284)
  19. Stock Exchanges  (4,129)
  20. Heart  (3,766)
  21. More options open sub menu

Language 

  1. Urdu  (50)
  2. Hindi  (10)
  3. More options open sub menu

Searching Remote Databases, Please Wait